检索结果 - Nur Hezrin Shahrin
- Showing 1 - 4 results of 4
-
1
-
2
-
3
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention 由 Naranie Shanmuganathan, Carol Wadham, Nur Hezrin Shahrin, Jinghua Feng, Daniel Thomson, Paul Wang, Verity A. Saunders, Chung Hoow Kok, Rob King, Rosalie Kenyon, Ming Lin, Ilaria S. Pagani, David M. Ross, Agnes S. M. Yong, Andrew Grigg, Anthony K. Mills, Anthony P. Schwarer, Jodi Braley, Haley Altamura, David T Yeung, Hamish S. Scott, Andreas Schreiber, Timothy P. Hughes, Susan Branford
出版 2023Artigo -
4
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease 由 Susan Branford, Paul Wang, David T Yeung, Daniel Thomson, Adrian Purins, Carol Wadham, Nur Hezrin Shahrin, Justine E. Marum, Nathalie Nataren, Wendy T Parker, Joel Geoghegan, Jinghua Feng, Naranie Shanmuganathan, Martin Mueller, Christian Dietz, Doris Stangl, Zoe Donaldson, Haley Altamura, Jasmina Georgievski, Jodi Braley, Anna Brown, Christopher N Hahn, Ieuan Walker, Soohyun Kim, Soo-Young Choi, Sa-Hee Park, Dong-Wook Kim, Deborah L. White, Agnes S. M. Yong, David M. Ross, Hamish S. Scott, Andreas Schreiber, Timothy P. Hughes
出版 2018Artigo
相关主题
Biology
Genetics
Cancer
Gene
Internal medicine
Medicine
Oncology
Bioinformatics
Cancer research
Disease
Mutation
Myeloid leukemia
ABL
Chromosomal translocation
Cohort
Computational biology
Confidence interval
Cumulative incidence
Fusion gene
Hazard ratio
Imatinib
Imatinib mesylate
Immunology
Missense mutation
Philadelphia chromosome
Proportional hazards model
Receptor
Tyrosine kinase
Tyrosine-kinase inhibitor